rs1278956954
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_006793.5(PRDX3):c.50T>C(p.Val17Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006793.5 missense
Scores
Clinical Significance
Conservation
Publications
- corneal dystrophy, punctiform and polychromatic pre-descemetInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia, autosomal recessive 32Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDX3 | NM_006793.5 | c.50T>C | p.Val17Ala | missense_variant | Exon 2 of 7 | ENST00000298510.4 | NP_006784.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1460864Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726760 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74388 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.50T>C (p.V17A) alteration is located in exon 2 (coding exon 2) of the PRDX3 gene. This alteration results from a T to C substitution at nucleotide position 50, causing the valine (V) at amino acid position 17 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at